This paper reviews current marketing practices in the pharmaceutical sector, examining both consumer and doctor-oriented promotion. It presents examples of marketing practices and their impact on consumer and doctor behaviour. It identifies negative impacts of these practices which include misleading advertising, disease mongering and escalating costs. It goes on to argue the need for an independently-monitored code of practice for marketers in the pharmaceutical sector and a greater degree of c